Neuromodulation Devices Consumables and Associated Products 2023

Description

"Non-exclusive Framework Agreement (FAG) for the supply to the NHS Supply Chain customer base via the E-Direct Route. Product range to include, but not limited to stimulation of; Deep Brain, Spinal Cord, Sacral Nerve, Vagal Nerve, Dorsal Route Ganglion, Peripheral Nerve, Radio Frequency Pain Management, Intrathecal Brug Delivery Pumps, Dorsal Ramus Medial Branch nerve and other devices that provide nerve stimulation or pain management that meet the requirements of users and patients. The FAG will provide access to Neuromodulation Devices/Consumables that are associated with Neuromodulation procedures. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £92,000,000.00 the term of FAG, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the FAG. The estimated value over the total FAG term (including any extension options) is £392,000,000.00" Lot Lot 1: Deep Brain Stimulation "Neuromodulation Product range to include, but not limited to the supply of; Deep Brain Stimulation. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £18m in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. " Lot Lot 2: Spinal Cord Stimulation "Neuromodulation Product range to include, but not limited to the supply of; Spinal cord Stimulation. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £34m in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. " Lot Lot 3: Additional Neuromodulation Therapies and Associated Products Neuromodulation Product range to include, but not limited to the supply of; Sacral Nerve, Vagal Nerve, Dorsal Route ganglion, Peripheral Nerve, Radio Frequency Pain Management, Intrathecal Brug Delivery Pumps and Dorsal Ramus Medial Branch nerve. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £32m in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Lot Lot 1: Deep Brain Stimulation "Neuromodulation Product range to include, but not limited to the supply of; Deep Brain Stimulation. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £18m in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. " Lot Lot 2: Spinal Cord Stimulation "Neuromodulation Product range to include, but not limited to the supply of; Spinal cord Stimulation. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £34m in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. " Lot Lot 3: Additional Neuromodulation Therapies and Associated Products Neuromodulation Product range to include, but not limited to the supply of; Sacral Nerve, Vagal Nerve, Dorsal Route ganglion, Peripheral Nerve, Radio Frequency Pain Management, Intrathecal Brug Delivery Pumps and Dorsal Ramus Medial Branch nerve. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £32m in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.